Special Session 1: Implications of Methylation and Genomics in Skull Base Pathology
17th February, 2023, 07:30 - 08:30
Tampa Bay 9
Treatment options for skull base pathologies have primarily focused on surgery and radiation. However, with advancing knowledge of methylation and genomics in skull base pathologies, further treatment options and risks stratification of these tumors may aid in how these tumors are managed. This session will focus on providing an update on emerging data regarding methylation and genomics in skull base pathology and how these will be used to further patient care. Any provider who cares for these tumors is encouraged to attend.
At the conclusion of this session, attendees will be able to:
- Recognize the role methylation and genomics play in skull base pathologies.
- Distinguish which patients are appropriate for pathology testing and how the results of testing will impact patient care.
- Identify where to find active clinical trials that utilize methylation and genomics in skull base pathology.
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
|Role of Methylation and Genomics in Skull Base Pathology||Speaker||7:30 am - 7:40 am|
|Wenya Linda Bi
|Skull Base Tumor Microenvironment||Speaker||7:40 am - 7:50 am|
|Genomics in Chordoma||Speaker||7:50 am - 8:00 am|
|Methylation and Genomics in Head and Neck Cancer of the Skull Base||Speaker||8:00 am - 8:10 am|
||Q&A||8:10 am - 8:30 am|